What does Leukostasis mean?

Leukostasis, also known as symptomatic hyperleukocytosis, is a life-threatening complication of various leukemias characterized by an excess of white blood cells in the bloodstream. Hyperleukocytosis is arbitrarily defined as greater than 100,000 white blood cells per microliter of blood.

What is pulmonary Leukostasis?

Pulmonary leukostasis is a life threatening condition that leads to respiratory failure. It should be considered in the differential diagnosis of patients with hematologic malignancy presenting with shortness of breath, desaturation, and elevated WBCs. Patients with AML, especially M5, have the highest risk.

Does CLL cause Leukostasis?

Leukostasis is very rare in CLL and is more commonly seen in acute leukemia (5–30%) [8,9]. While hyperleukocytosis is often seen in a significant proportion of patients with CLL [7], end-organ damage presenting with signs and symptoms is rarely seen.

How is Leukostasis treated?

Current treatment options for leukostasis include mechanical removal of leukemic blasts with leukapheresis and cytoreduction with chemotherapy or hydroxyurea.

How is Hyperleukocytosis CML treated?

The main goal for patients with hyperleukocytosis is to reduce the leukocyte count rapidly and safely to minimize the risk for the development of clinical leukocytosis. Depending on risk, measures to consider include (1) use of cytotoxic chemotherapy; (2) hydroxyurea; and (3) leukapheresis.

When do you do leukapheresis?

Ordinarily, leukapheresis is initiated in a patient with acute myeloid leukemia (AML) or in the accelerated phases of chronic myeloid leukemia (CML) when the blast count exceeds 100,000/mm3 or when rapidly rising blast counts are higher than 50,000/mm3, especially when evidence of central nervous system or pulmonary …

How long does leukapheresis last?

The procedure takes approximately two to three hours to complete. Although leukapheresis is not painful, some patients are uncomfortable sitting or lying in the same place for the duration of the procedure.

What causes Hyperleukocytosis?

Stressors capable of causing an acute leukocytosis include surgery, exercise, trauma, and emotional stress. Other nonmalignant etiologies of leukocytosis include certain medications, asplenia, smoking, obesity, and chronic inflammatory conditions.

What is CML diagnosis?

Chronic myelogenous leukemia (CML) is an uncommon type of cancer of the bone marrow — the spongy tissue inside bones where blood cells are made. CML causes an increased number of white blood cells in the blood.

What is the difference between leukapheresis and apheresis?

Apheresis is a procedure used to fractionate whole blood into its individual components. Leukapheresis is one type of apheresis where leukocytes (white blood cells) are selectively removed. This procedure is commonly used for blood transfusions to remove donor leukocytes from being transferred to the recipient.

What is the meaning of leukapheresis?

Listen to pronunciation. (LOO-kuh-feh-REE-sis) Removal of the blood to collect specific blood cells. The remaining blood is returned to the body.

What are the symptoms of leukostasis in leukemia?

In general, symptoms of leukostasis are more common in leukemias with large, poorly deformable blasts, such as acute myeloid leukemia. ● Acute myeloid leukemia – Hyperleukocytosis is present in 10 to 20 percent of patients with newly diagnosed acute myeloid leukemia (AML).

What is the incidence of hyperleukocytosis and leukostasis in leukemia?

The incidence of hyperleukocytosis and leukostasis vary by leukemia type and patient population. In general, symptoms of leukostasis are more common in leukemias with large, poorly deformable blasts, such as acute myeloid leukemia.

How common is leukostasis in patients with acute promyelocytic leukemia (FAB-M3)?

It is more common in patients with myelomonocytic (FAB-M4) leukemia, monocytic (FAB-M5) leukemia, or the microgranular variant of acute promyelocytic leukemia (FAB-M3) [ 1,2 ]. Symptoms of leukostasis occur less frequently and typically affect patients with white blood cell (WBC) counts over 100 x 10 9 /L (100,000/microL).

What is the mortality of asymptomatic leukostasis?

Asymptomatic hyperleukocytosis / symptomatic hyperleukocytosis (leukostasis) Continued and untreated leukostasis presents respiratory and neurological distress simultaneously and is a medical emergency, with untreated patient mortality rates reaching a minimum of 20 and a maximum of 40 percent..